Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 400 | 544 | 43 | 200 | 621 |
| Receivables | 140 | 109 | 16 | 26 | 28 |
| TOTAL | $568 | $673 | $68 | $227 | $650 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $568 | $673 | $68 | $227 | $650 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 474 | N/A | N/A | N/A | 180 |
| Accrued Expenses | 111 | N/A | N/A | N/A | N/A |
| TOTAL | $585 | $235 | $282 | $154 | $180 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,885 | 1,483 | 349 | 330 | 328 |
| TOTAL | $2,885 | $1,483 | $349 | $330 | $328 |
| Total Liabilities | $3,470 | $1,718 | $631 | $484 | $508 |
| Shareholders' Equity | |||||
| Common Shares | 12,027 | 11,806 | 10,223 | 9,619 | 9,292 |
| Retained earnings | -17,783 | -15,608 | -12,410 | -10,482 | -9,476 |
| Other shareholders' equity | 15 | 0 | 0 | 0 | 0 |
| TOTAL | $-2,902 | $-1,046 | $-563 | $-257 | $141 |
| Total Liabilities And Equity | $568 | $673 | $68 | $227 | $650 |